Global Organ Preservation Market Size Insights Forecasts to 2032
- The Global Organ Preservation Market Size was valued at USD 0.26 Billion in 2022.
- The Market Size is Growing at a CAGR of 7.2% from 2022 to 2032
- The Worldwide Organ Preservation Market Size is expected to reach USD 0.52 Billion by 2032
- Asia-Pacific is expected to Grow higher during the forecast period
Get more details on this report -
The Global Organ Preservation Market Size is expected to reach USD 0.52 Billion by 2032, at a CAGR of 7.2% during the forecast period 2022 to 2032.
Organ preservation refers to the techniques and processes employed to maintain the viability and function of organs outside of the body, typically for transplantation purposes. The main goal of organ preservation is to extend the time between organ retrieval from a donor and transplantation into a recipient, thereby increasing the chances of a successful transplant. Various methods are employed, such as cold storage, where organs are cooled to reduce metabolic activity, and perfusion-based preservation, involving the continuous supply of oxygenated solutions. Recent advancements include hypothermic perfusion and normothermic machine perfusion, which enable better preservation of organs, especially marginal ones. Organ preservation plays a pivotal role in bridging the gap between organ shortage and the growing demand for life-saving transplants.
This research report categorizes the market for organ preservation market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the organ preservation market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the organ preservation market.
Global Organ Preservation Market Report Coverage
|Market Size in 2022:||USD 0.26 Billion|
|Forecast Period 2022-2032 CAGR:||7.2%|
|2032 Value Projection:||USD 0.52 Billion|
|Historical Data for:||2018-2021|
|No. of Pages:||200|
|Tables, Charts & Figures:||110|
|Segments covered:||By Solution, By Technique, By Organ Type, By End-User, By Region and COVID-19 Impact Analysis.|
|Companies Covered:||Paragonix Technologies, XVIVO Perfusion AB, Dr. Franz Kohler Chemie GmbH, Essential Pharmaceuticals, LLC, TransMedics, OrganOx Limited, Shanghai Genext Medical Technology, Bridge to Life Limited, Waters Medical Systems, Preservation Solutions, Carnamedica, Transplant Biomedicals, Global Transplant Solutions, and other key vendors.|
|Pitfalls & Challenges:||COVID-19 Empact, Challenge, Future, Growth, & Analysis|
Get more details on this report -
The organ preservation market is driven by a confluence of factors that collectively contribute to its growth and significance, the increasing prevalence of end-stage organ failure and chronic diseases has fueled the demand for organ transplantation as a vital treatment option. This, coupled with advancements in surgical techniques and immunosuppressive therapies, has amplified the need for effective organ preservation methods to ensure successful transplantation outcomes. The widening gap between organ supply and demand has necessitated the development of sophisticated preservation techniques to expand the pool of transplantable organs. Organ shortages persist due to factors like limited organ donors, logistical challenges in organ transportation, and the stringent criteria for organ viability. As a result, research and innovation in preservation technologies, such as hypothermic and normothermic machine perfusion, have gained prominence to optimize organ quality and extend preservation times, thus addressing the scarcity issue. The rising investments and funding for research and development activities in the field of organ preservation have propelled technological advancements. These investments have led to the creation of novel solutions, including organ preservation solutions, perfusion systems, and preservation chambers that enhance the preservation process, minimize ischemic damage, and increase the chances of transplant success.
The growing emphasis on personalized medicine has also influenced the organ preservation market. Tailoring preservation methods to specific organs and individual patient characteristics can enhance transplant outcomes by minimizing the risk of rejection and complications. This personalized approach requires the integration of advanced diagnostics, monitoring systems, and preservation strategies, driving further research and commercial interest. Furthermore, regulatory reforms and initiatives to streamline organ donation and transplantation practices have shaped the organ preservation market's landscape. Governments and healthcare organizations are working to improve the organ procurement process, optimize allocation algorithms, and establish quality standards for preservation techniques.
Organ preservation market growth faces restraints including the complexity of preservation methods leading to higher costs, limited availability of skilled professionals to handle advanced preservation technologies, ethical concerns surrounding organ transplantation, and regulatory challenges in ensuring safety and efficacy of new preservation techniques. Additionally, the relatively slow pace of regulatory approvals for novel methods, potential risks of ischemic injury during the preservation process, and concerns about long-term graft function post-transplantation present obstacles to the seamless expansion of the market.
- In 2022, the UW solutions segment accounted for around 35.6% market share
On the basis of the solution, the global organ preservation market is segmented into university of wisconsin solution, custodial HTK, perfadex, and others. The University of Wisconsin (UW) solutions segment occupies the largest share in the organ preservation market due to its established efficacy and widespread adoption. UW solutions offer a balanced electrolyte composition and protective agents, which effectively minimize cellular damage during preservation. These solutions have a proven track record in improving organ viability and transplant success rates. Their versatility in preserving various organs, along with extensive clinical validation, has solidified their dominance. Surgeons' familiarity with UW solutions, coupled with their relatively cost-effective nature, further contribute to their significant market presence.
- The static cold storage segment held the largest market with more than 32.5% revenue share in 2022
Based on the technique, the global organ preservation market is segmented into static cold storage, hypothermic machine perfusion, and normothermic machine perfusion. The static cold storage segment commands the largest share in the organ preservation market due to its long-standing presence and simplicity. Static cold storage involves cooling organs to low temperatures, slowing metabolism and preserving organ function. Its wide adoption is attributed to its ease of use, cost-effectiveness, and established clinical track record. Surgeons are familiar with this method, and its suitability for a range of organs contributes to its dominance. While emerging technologies offer advantages, the well-established and reliable nature of static cold storage continues to make it a preferred choice for many organ transplantation procedures.
- The kidney segment held the largest market with more than 29.7% revenue share in 2022
Based on the organ type, the global organ preservation market is segmented into kidney, liver, lung, heart, and pancreas. The kidney segment commands the largest share in the organ preservation market due to several factors. Kidney transplantation is the most common type of organ transplant, driven by a high prevalence of end-stage renal diseases. Organ preservation plays a critical role in ensuring successful kidney transplants, as kidneys are sensitive to ischemic damage. Advances in preservation techniques, especially hypothermic and normothermic perfusion, have significantly improved kidney viability and transplant outcomes. The increasing availability of kidneys from deceased and living donors further fuels the demand for effective preservation methods, consolidating the kidney segment's dominant market position.
- The organ transplant centers segment to grow at a highest CAGR of around 7.4% during the forecast period
Based on the end-user, the global organ preservation market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment is anticipated to experience the highest growth in the organ preservation market during the forecast period due to its pivotal role in transplantation processes. As these centers continuously seek to enhance patient outcomes, they are increasingly adopting advanced organ preservation technologies to improve graft quality and transplant success rates. Moreover, collaborations between transplant centers and research institutions drive innovation, fostering the adoption of cutting-edge preservation methods. This focus on optimizing transplantation procedures positions the organ transplant centers segment for substantial growth in the coming years.
Regional Segment Analysis of the Organ Preservation Market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America dominated the market with more than 42.6% revenue share in 2022.
Get more details on this report -
Based on region, North America dominates the organ preservation market due to several factors. Advanced healthcare infrastructure, a robust network of transplant centers, and a high prevalence of chronic diseases driving the need for organ transplantation contribute to its leadership. Moreover, the region's substantial investments in research and development, coupled with collaborations between academic institutions and industry players, accelerate innovation in organ preservation technologies. Regulatory frameworks that streamline transplantation processes also bolster the market.
Asia-Pacific region is expected to accelerate growth in the organ preservation market during the forecast period due to rising healthcare expenditure, improving healthcare infrastructure, and a growing awareness of transplantation as a treatment option are driving increased demand for organ preservation technologies. Additionally, the region's large population base provides a significant pool of potential organ donors and recipients.
- In August 2022, Paragonix Technologies, Inc. has reached a key milestone of preserving over 2,000 donor organs while also delivering Advanced Organ Preservation (AOPT) technology and a statewide clinical support network to transplant institutions. Each of these technologies uses novel preservation methods and has shown to be a considerable improvement over traditional ice and cooler practises.
- In January 2022, a university offshoot OrganOx, a global leader in normothermic machine perfusion (NMP), has announced that the FDA has granted premarket approval (PMA) for its metra system. OrganOx metra is a novel organ preservation device developed by Biomedical Engineering and Surgery researchers.
The report offers the appropriate analysis of the key organizations/companies involved within the global organ preservation market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Companies:
- Paragonix Technologies
- XVIVO Perfusion AB
- Dr. Franz Kohler Chemie GmbH
- Essential Pharmaceuticals, LLC
- OrganOx Limited
- Shanghai Genext Medical Technology
- Bridge to Life Limited
- Waters Medical Systems
- Preservation Solutions
- Transplant Biomedicals
- Global Transplant Solutions
Key Target Audience
- Market Players
- Government Authorities
- Consulting and Research Firm
- Venture Capitalists
- Value-Added Resellers (VARs)
This study forecasts revenue at global, regional, and country levels from 2019 to 2032. Spherical Insights has segmented the global organ preservation market based on the below-mentioned segments:
Organ Preservation Market, By Solution
- University of Wisconsin Solution
- Custodial HTK
Organ Preservation Market, By Technique
- Static Cold Storage
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
Organ Preservation Market, By Organ Type
Organ Preservation Market, By End-User
- Organ Transplant Centers
- Specialty Clinics
Organ Preservation Market, Regional Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- South America
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Need help to buy this report?